Immunoprotective determinants in friend murine leukemia virus envelope protein

被引:36
作者
Hasenkrug, KJ
Brooks, DM
Robertson, MN
Srinivas, RV
Chesebro, B
机构
[1] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
[2] Univ Washington, Med Ctr, Retrovirus Lab, Div Infect Dis,Dept Med, Seattle, WA 98195 USA
[3] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
关键词
D O I
10.1006/viro.1998.9264
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several immunological epitopes are known to be located within the Friend murine leukemia virus (F-MULV) envelope protein, but their relative contributions to protection from Friend virus-induced disease are not known. To determine how expression of various immunological determinants affected protection, mice were immunized with recombinant vaccinia viruses expressing different portions of the FMuLV envelope protein, and they were then challenged with a lethal dose of Friend virus complex. The disease parameters that were followed in the mice were early viremia, early splenomegaly, and late splenomegaly. Both the N-terminal and C-terminal portions of the F-MuLV gp70 were found to protect against late splenomegaly, the primary clinical sign associated with virus-induced erythroleukemia. However, neither region alone protected against early splenomegaly and early viremia, indicating poor immunological control over early virus replication and spread through the spleen and blood. In contrast, mice immunized with a vaccine expressing the entire F-MuLV envelope protein were protected against all three disease parameters. The results indicated that expression of multiple immunological determinants including both T-helper and B cell epitopes was necessary for full protection. (C) 1998 Academic Press.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 44 条
[1]   What is required of an HIV vaccine? [J].
Bangham, CRM ;
Phillips, RE .
LANCET, 1997, 350 (9091) :1617-1621
[2]  
Bolognesi DP, 1996, ANTIBIOT CHEMOTHER, V48, P63
[3]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[4]  
BRITT WJ, 1983, J IMMUNOL, V130, P2363
[5]  
CEASE KB, 1994, ANNU REV IMMUNOL, V12, P923, DOI 10.1146/annurev.iy.12.040194.004423
[7]   CHARACTERIZATION OF MOUSE MONOCLONAL-ANTIBODIES SPECIFIC FOR FRIEND MURINE LEUKEMIA VIRUS-INDUCED ERYTHROLEUKEMIA-CELLS - FRIEND-SPECIFIC AND FMR-SPECIFIC ANTIGENS [J].
CHESEBRO, B ;
WEHRLY, K ;
CLOYD, M ;
BRITT, W ;
PORTIS, J ;
COLLINS, J ;
NISHIO, J .
VIROLOGY, 1981, 112 (01) :131-144
[8]   PERSISTENCE OF INFECTIOUS FRIEND-VIRUS IN SPLEENS OF MICE AFTER SPONTANEOUS-RECOVERY FROM VIRUS-INDUCED ERYTHROLEUKEMIA [J].
CHESEBRO, B ;
BLOOM, M ;
WEHRLY, K ;
NISHIO, J .
JOURNAL OF VIROLOGY, 1979, 32 (03) :832-837
[9]   HOST GENETIC-CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALY - MAPPING OF A GENE WITHIN MAJOR HISTOCOMPATABILITY COMPLEX [J].
CHESEBRO, B ;
WEHRLY, K ;
STIMPFLING, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (06) :1457-1467
[10]  
CHESEBRO B, 1990, ANNU REV IMMUNOL, V8, P477, DOI 10.1146/annurev.iy.08.040190.002401